Bausch & Lomb and pharmaceutical company Santen have entered into a partnership together for lens development.
The agreement, for developing materials for intraocular lenses (IOLs), allows Bausch & Lomb to commercialise such lenses through use of hydrophobic acrylic polymers from Santen.
Details of the finances involved in the licensing agreement are not being publicly released, although the terms leave Santen with the rights for the material within Japan.
Tom Frinzi, vice-president for global commercial operations at Bausch & Lomb, said that the hydrophobic acrylic polymers were "novel materials" that improved the company"s standing for the IOL market.
Last month, Bausch & Lomb announced that a new promotional drive was underway for one of its IOL products, the Crystalens.
The advertising campaign, launched in Florida, targets senior citizens and baby boomers and uses several different channels including radio and television.
Amy Jacobs, Crystalens director of global marketing, said that anyone who is to have cataract surgery should inquire about Crystalens.
by Alexa Kaczka